According to a study of 3,047 trauma patients, most experience moderately severe pain one year after injury. Pain severity is highest in joints and extremities, and varies by age and sex, with younger adults more likely to experience pain than older adults.
The American Academy of Pain Medicine acknowledges chronic pain as a major disease entity, requiring targeted therapies. Studies estimate over 76 million Americans experience chronic pain, resulting in $1.85 billion annual cost.
Researchers present studies on the relationship between smoking and neuropathic pain, the benefits of physical conditioning in chronic pain patients, and the effectiveness of pain rehabilitation programs in reducing medication costs. These findings highlight the importance of addressing underlying causes of chronic pain and exploring n...
A study by Northwestern University's Feinberg School of Medicine found that chronic pain disrupts the equilibrium of the brain's regions, leading to permanent damage. This constant firing of neurons can alter connections and even cause death.
Researchers at Mount Sinai School of Medicine have discovered a novel targeted gene therapy that simulates the pain-killing effect of opiate drugs, providing relief for more than three months after a single injection. The technique targets selectively the pain gate, avoiding unwanted side effects associated with opioid painkillers.
Researchers found peroxynitrite plays a crucial role in opiate-induced antinociceptive tolerance in mice. Accumulation of tyrosine-nitrated proteins and oxidative DNA damage were associated with this process.
The International Association for the Study of Pain (IASP) has declared 2008 as the Global Year Against Pain in Women, highlighting the suffering caused by disparities in pain recognition and treatment. The campaign aims to increase awareness, empower women to seek proper treatment, and improve access to healthcare services.
A study at McGill University Health Centre shows that combining methadone with innovative case management can provide relief for patients with chronic pain. The program, which includes regular phone calls and a pain diary, resulted in 57% of patients being satisfied or very satisfied after nine months.
A recent study found that chronic pain patients taking opioid therapy are at a higher risk of developing sleep apnea. The research, published in Pain Medicine, suggests a direct dose-response relationship between central sleep apnea and methadone and benzodiazepines.
Researchers at the University of Manchester have uncovered the structure of a key pain molecule, P2X receptors, using microscopic slime moulds. This breakthrough could lead to the development of new painkillers for chronic conditions like migraine and backache.
A Northwestern University researcher has found that old memory traces in the prefrontal cortex may trigger chronic pain. The discovery led to a new drug, D-Cycloserine, which controls persistent nerve pain by targeting the emotional suffering of pain.
Scientists have identified the TRPM8 receptor as responsible for sensing cold, which also mediates pain perception. The study provides a target for treating acute and chronic pain.
This article discusses various aspects of pain management, including the impact of depression and posttraumatic stress disorder (PTSD) on patient satisfaction. The study found that patients with both conditions were more likely to have a chronic medical condition and greater physical and psychosocial stressors.
Researchers at the University of Alberta have confirmed that chronic pain affects attention and memory in 67% of participants. Chronic pain can disrupt the maintenance of the memory trace required to hold information for processing.
A new study published in the journal Sleep found that sleep disturbance increases spontaneous pain in women. The study, conducted by Michael T. Smith and colleagues, used polysomnography to assess 32 healthy females and found that fragmented sleep profiles led to impaired natural pain control mechanisms.
Chronic pain has increased by 26% among US workers over the past decade, with most employees experiencing moderate to severe pain while still attending work. Employers are encouraged to invest in workplace wellness programs addressing chronic pain, as only 22% currently include such components.
A new review of studies found that psychological interventions are effective in reducing pain intensity and improving health-related quality of life. These approaches also yield improvements in depression, work-related disability, and daily living.
A study at UNC Chapel Hill found that specific genetic variants of the COMT gene can affect pain processing by altering messenger RNA secondary structure. The discovery may lead to more effective treatments for TMJD and other chronic pain conditions.
A randomized controlled trial found that osteoarthritis patients who received acupuncture treatment in addition to routine care showed significant improvements in symptoms and quality of life. The study's results suggest that acupuncture can be an effective treatment option for OA patients, with benefits lasting beyond the therapy period.
A specific gene variant, GCH1, affects both acute and chronic pain sensitivity in humans. The protective version of the gene reduces the risk of developing chronic post-surgical pain.
A large study found that patients with IBS are 60% more likely to suffer from depression, migraine, or chronic pain compared to those without IBS. Individuals with IBS were also 40% more likely to experience depression and 60% more likely to suffer from migraine.
A study by University of Rochester researchers found that young age, extensive surgery, and severe post-operative pain are risk factors for developing chronic pain after breast cancer surgery. The study suggests that counseling and analgesic drugs immediately after surgery may help prevent long-term problems.
Researchers at Kent State University found that guided imagery significantly reduced patients' chronic pain experiences, making it easier to control. The study, published in Pain Management Nursing, suggests alternative therapies like guided imagery can complement medication therapy for effective pain management.
A new synthetic treatment has been discovered that uses cooling chemicals to kill pain, targeting the TRPM8 receptor in human skin. This approach may offer a more effective and safer alternative to conventional painkillers for chronic pain patients.
Researchers have identified a protein called TRPM8 that mediates sensations of coolness and is expressed in nerve cells in the skin, responding to both cool temperatures and cooling chemicals like mint oil. This discovery has great potential for relieving chronic pain patients with approaches using cooling compounds
Researchers at Columbia University Medical Center have discovered a protein switch that activates chronic pain. The switch is an enzyme called protein kinase G (PKG), which sets off processes generating pain messages when activated. Turning PKG off relieves pain, making it a potential target for therapy.
Researchers found that targeting women's depression can help reduce disability associated with chronic pain. Women are more likely to experience higher levels of depression and greater pain intensity than men, and may respond differently to treatments.
New research suggests targeting affected nerves and spinal cords may provide relief from chronic neuropathic pain. The study found changes in spinal cord neurons after sciatic nerve constriction injury, but the exact mechanisms remain unclear.
Chronic pain in elderly population projected to increase by 75% between 2010 and 2030, with limited effective treatment options. Dr. Debra Weiner emphasizes the need for more research to better treat chronic pain in older adults.
The American Academy of Pain Medicine calls for a balance between treating legitimate pain and preventing misuse, with healthcare professionals at the forefront. Government initiatives have shifted regulatory authority from health agencies to law enforcement, leading to tension and imbalance in pain care.
Research on hurricane Katrina victims reveals a correlation between self-reported pain, stress, and fear. The study also found that patients demonstrated resilience in coping with chronic pain after the disaster, focusing on survival rather than pain.
A study published in Mayo Clinic Proceedings found that 22.4% of people with chronic pain did not inform their physician about it, likely due to poor experiences or barriers to healthcare. The study highlights the need for better pain management and increased awareness among healthcare professionals.
Researchers have discovered that CRPS-I patients exhibit reduced small-fiber nerve endings, leading to abnormal neural function and increased sensitivity. The study provides an identified cause for the condition, shifting its classification from 'psychosomatic illness'.
The average annual cost of treating and managing adolescent pain is over £8,000 per patient, with a conservative estimate of £3.8 billion for the UK as a whole. Chronic pain in adolescence has significant financial and social consequences, including high levels of distress, increased healthcare usage, and reduced academic performance.
Researchers used real-time functional MRI to show healthy subjects and patients with chronic pain can control brain activity to modulate pain levels. The study suggests a potential new treatment approach for chronic pain patients without relying on expensive equipment.
A study of people with fibromyalgia found those with greater hour-to-hour and day-to-day variability in their pain levels were more likely to respond to placebos. The researchers used electronic diaries to track participants' pain levels, which proved more accurate than previous methods.
A new study finds black women with chronic pain experience higher levels of disability, post-traumatic stress disorder, and emotional impairment compared to white women. The research emphasizes the need for improved access to quality pain care and a better understanding of minority patients' needs.
Researchers at UF found dextromethorphan, commonly used in cough remedies, reduces fibromyalgia 'wind-up' pain. The study suggests the drug may eventually be an option for treating fibromyalgia and other conditions involving heightened pain sensitivity.
A recent study found that fibromyalgia patients' level of depression has little impact on their intensity of pain experience, suggesting that treatments for each condition should be considered separately. Researchers hope that separating these two complex conditions can lead to more effective pain management.
Researchers studied brain activity in fibromyalgia patients to understand depression-pain connection. They found heightened sensitivity to pressure-induced pain in FM patients, regardless of depressive symptoms. The study suggests treating depression and physical pain separately for better outcomes.
Researchers found that people with fibromyalgia have similar average activity levels as those without the condition, but lower high-intensity activities. This study suggests a more nuanced understanding of fibromyalgia and could lead to changes in treatment.
A study by researchers at Michigan Medicine and the University of South Florida found a significant generation gap in chronic pain coping among black and white adults. Older adults generally scored higher on pain intensity and disability measurements, but younger adults experienced more depression symptoms and sleep disturbances.
Chronic pain is classified as a disease due to its definition in the Oxford English dictionary and persistence beyond initial symptoms. The financial costs of chronic pain are significant, comparable to those of cancer and heart disease.
A study published in The Journal of Neuroscience found that chronic back pain is associated with a significant decrease in gray matter volume in the brain, particularly in regions involved in processing information and memory. This suggests that proper treatment may reverse some of the brain changes caused by chronic pain.
A new neurostimulation system uses continuous electric field adjustments to provide real-time, dynamic paresthesia steering for improved pain relief. This innovative technology enables up to 71 combinations of stimulation settings, leading to enhanced therapeutic possibilities.
The KRONUS-MSP trial found that switching to sustained-release opioid Kadian improves pain relief and quality of life, while reducing the need for medication. Patients who previously exceeded recommended doses of OxyContin or MS Contin found relief with Kadian.
Researchers developed a new technique to selectively delete C-fiber neurons, which transmit chronic pain signals, using the drug resiniferatoxin. In animal studies, this approach reduced pain and improved behavior without side effects.
Researchers found that 3% of women report chronic pain and 1.7% currently have pain, affecting millions across the US. The study also revealed that African-American women are as likely to experience vulvodynia as Caucasian women.
Researchers found naked mole-rats naturally lack Substance P, a neurotransmitter that sends pain signals to the central nervous system. Introducing Substance P restored pain signaling in these animals, sparking hope for new therapies to treat fibromyalgia.
A study found that patients with unexplained chronic fatigue had nine times more prevalent sinus symptoms than the control group, and six times more common in those with unexplained chronic pain. Sinusitis may be a contributing factor to chronic fatigue syndrome in some cases.
African Americans with chronic pain experience significantly more symptoms than whites when seeking treatment, including greater levels of pain, depression, and impairment. Economic factors also play a significant role in producing these disparities.
A Stanford study found a significant link between depression and chronic pain, suggesting that pain may guide doctors to effective treatments for depressed patients. The research also indicates that continuous pain increases the likelihood of major depressive disorder diagnosis.
Researchers at the University of Melbourne have developed a new compound, ACV1, derived from cone shell venom that is more powerful and longer-lasting than morphine. The compound has shown promising results in laboratory studies, treating pain by blocking transmission along peripheral nervous systems without addictive side effects.
A new study reveals that rats with chronic pain from inflammation were more tolerant of painful heat stimuli and had less swelling when fed a diet based on soy protein. The findings suggest that a soy diet may reduce the need for opioid medications, which are often associated with severe side effects.
A study of 4,832 medical residents found that one-tenth feel unprepared to handle tasks like HIV/AIDS treatment, substance abuse, and chronic pain management. Residents reported a positive view of their training for common clinical problems but expressed concern about inadequate preparation for non-traditional patient populations.
A systematic review of literature found an association between positive expectations and improved outcomes in myocardial infarction, cardiac surgery, chronic pain, and psychiatric conditions. The mechanisms behind this association are still uncertain, with questions surrounding causality versus prediction.
A recent survey in the Netherlands reveals that chronic pain affects approximately 18% of the population, with frequent problems including lower back pain and abdominal pain. The study highlights the need for more research into the effects of treatment methods, as current evidence is often inadequate or contradictory.
Scientists have relieved pain in rats by dispatching molecular 'smart bombs' to selectively destroy certain nerve cells in the spinal cord, targeting faulty signaling by a small group of neurons. This approach targets just those nerve cells that send pain messages to the brain without causing side effects like morphine or surgery.
Researchers at the University of Florida found that women with chronic pain report slightly higher levels of pain than men. This difference may be attributed to how society teaches men to handle discomfort, rather than biology alone. The study's findings have long-term implications for treating male and female patients differently.
University of Florida researchers report that psychological effects of chronic pain are more disruptive to daily life than the pain itself. The study found that nearly 200 patients with TMD experienced depression, anger, and anxiety due to their condition.